跳至主要内容
临床试验/CTRI/2025/11/097720
CTRI/2025/11/097720尚未招募2 期

Evaluating The Effectiveness Of Individualized Homoeopathic Medicines In Cases Of Vitamin B12 Deficiency Or Insufficiency; An Open-Label, Prospective, Interventional Study

National Institute of Homoeopathy Kolkata1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2025年11月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
41
试验地点
1
主要终点
For each enrolled case, the serum Vitamin B12 levels will be recorded at baseline

研究概览

简要总结

Vitamin B12 is a water soluble vitamin which contains the mineral cobalt. Hence, compounds with vitamin B12 activity are collectively called cobalamins. It plays a crucial role in several vital processes in the body including development, myelination, and function of the central nervous system, healthy red blood cell formation, and DNA synthesis. Vitamin B12 deficiency refers to a condition in which the serum concentration of vitamin B12 (cobalamin) falls below the normal physiological range, leading to impaired DNA synthesis, haematopoiesis, and neurological function. It is typically defined biochemically as serum vitamin B12 level less than 200 pg/mL and borderline deficiency (insufficiency) 200–300 pg/mL. The primary objective of this study is to compare the changes in serum Vitamin B12 levels in cases of Vitamin B12 deficiency or insufficiency when Individualized Homoeopathic Medicine is used as an intervention over a period of 3 months. A minimum of 41 patients will be enrolled. A follow up of each case will be taken on a monthly basis for a period of 3 months and serum vitamin B12 will be checked at baseline and after 3 months.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • a) Patients with serum Vitamin B12 levels less than or equal to 300 pg/mL b) Patients between 18-70 years of age, all sexes, all religions and races irrespective of socioeconomic status.
  • c) Patients willing to take part in the study and fill the respective consent forms.

排除标准

  • a) Patients under use of medications affecting vitamin B12 levels – Metformin, proton pump inhibitors, H2 blockers.
  • b) Patients under the use of vitamin B12 supplements.
  • c) Patients with chronic alcoholism or substance abuse.
  • d) Pregnant and lactating women.
  • e) Patients having any terminal disease condition.

结局指标

主要结局

For each enrolled case, the serum Vitamin B12 levels will be recorded at baseline

时间窗: 0 month, 3 months

and then again after 3 months using Chemiluminescence Immunoassay (CLIA) technique and its changes

时间窗: 0 month, 3 months

will then be observed and recorded. The efficacy of Individualized Homoeopathic Medicines will be seen

时间窗: 0 month, 3 months

in the cases of Vitamin B12 deficiency or insufficiency.

时间窗: 0 month, 3 months

次要结局

未报告次要终点

研究者

发起方
National Institute of Homoeopathy Kolkata
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Bodu Sanghavi

National Institute of Homoeopathy, Kolkata

研究点 (1)

Loading locations...

相似试验